www.fdanews.com/articles/84322-nasal-spray-pitched-for-brittle-bones
NASAL SPRAY PITCHED FOR BRITTLE BONES
February 3, 2006
A Washington state-based pharmaceutical company will let Procter & Gamble
Co. develop and market its nasal spray for treatment of osteoporosis, the companies
said Wednesday. Nastech Pharmaceutical Company Inc. of Bothell, Wash., said
it will grant P&G rights to the worldwide development and commercialization
of its parathyroid hormone nasal spray. Terms of the deal include a $10 million
initial payment, with additional goal-based payments that could reach $577 million
over the life of the agreement.
The
Daily News Online